On March 20, 2017, the Food and Drug Administration (“FDA”) published a notice in the Federal Register delaying the implementation of the final rule (“Final Rule”) regulating off-label drug promotion until March 19, 2018. The Final Rule was published in the Federal Register of January 9, 2017. The effective date was originally delayed until March…Read More
FDA Delays New Rule for Off-Label Promotion
Posted on March 23, 2017 in Health Law News
Published by: Hall Render